---
title: "ZeZentalis Pharma (ZNTL.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ZNTL.US/norm.md"
symbol: "ZNTL.US"
name: "ZeZentalis Pharma"
parent: "https://longbridge.com/en/quote/ZNTL.US.md"
datetime: "2026-05-20T13:54:49.175Z"
locales:
  - [en](https://longbridge.com/en/quote/ZNTL.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ZNTL.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ZNTL.US/norm.md)
---

# ZeZentalis Pharma (ZNTL.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.5031 | -0.4914 | -0.3700 | -0.3733 | -0.6736 |
| ROE | -70.90% | -60.06% | -40.49% | -37.73% | -61.06% |
| Revenue | - | - | - | - | - |
| Net income | -35.35M | -35.22M | -26.69M | -26.87M | -48.28M |
| Operating income | -37.85M | -34.46M | -33.73M | -34.91M | -37.83M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 253.07M | 288.97M | 327.25M | 351.71M | 384.02M |
| Leverage | 1.39 | 1.34 | 1.29 | 1.28 | 1.30 |
| BVPS | 2.57 | 3.13 | 3.50 | 3.81 | 4.11 |
| Turnover | - | - | 0.0691 | 0.0637 | 0.0571 |
| Cash & STI | 211.76M | 245.89M | 280.70M | 303.43M | 332.45M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 28.25M | 29.04M | 33.12M | 34.26M | 35.17M |
| Net debt | -177.11M | -206.32M | -240.24M | -262.11M | -290.29M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -32.96M | -30.94M | -26.96M | -34.71M | -32.64M |
| Investing CF | 30.01M | 32.45M | 28.32M | 30.38M | 40.48M |
| Financing CF | -1.12M | -4.59M | 115000.00 | 0.0000 | 189000.00 |
| Free CF | -20.03M | -18.68M | -17.51M | -23.63M | -16.07M |
| OCF coverage | -96929.41% | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | -34000.00 | - | - | - | - |